Alpha Tau Medical Ltd. (DRTS) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 3 Buy, 1 Hold.
The consensus price target is $12.00, representing an upside of 53.3% from the current price $7.83.
Analysts estimate Earnings Per Share (EPS) of $-0.45 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.45 vs est $-0.45 (beat +0%). 2025: actual $-0.53 vs est $-0.51 (missed -3.8%). Analyst accuracy: 98%.
DRTS Stock — 12-Month Price Forecast
$12.00
▲ +53.26% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Alpha Tau Medical Ltd., the price target is $12.00.
The average price target represents a +53.26% change from the last price of $7.83.
DRTS Analyst Ratings
Buy
Based on 4 analysts giving stock ratings to Alpha Tau Medical Ltd. in the past 3 months
EPS Estimates — DRTS
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.45
vs Est –$0.45
▼ 0.0% off
2025
Actual –$0.53
vs Est –$0.51
▼ 3.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — DRTS
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
